[go: up one dir, main page]

NO304260B1 - Tablett for programmert avgivelse av naproksen - Google Patents

Tablett for programmert avgivelse av naproksen

Info

Publication number
NO304260B1
NO304260B1 NO933177A NO933177A NO304260B1 NO 304260 B1 NO304260 B1 NO 304260B1 NO 933177 A NO933177 A NO 933177A NO 933177 A NO933177 A NO 933177A NO 304260 B1 NO304260 B1 NO 304260B1
Authority
NO
Norway
Prior art keywords
naproxen
released
therapeutic
tablet
tablets
Prior art date
Application number
NO933177A
Other languages
English (en)
Norwegian (no)
Other versions
NO933177L (no
NO933177D0 (no
Inventor
Egidio Marchi
Leone Gabriele Rotini
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of NO933177D0 publication Critical patent/NO933177D0/no
Publication of NO933177L publication Critical patent/NO933177L/no
Publication of NO304260B1 publication Critical patent/NO304260B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO933177A 1992-09-11 1993-09-07 Tablett for programmert avgivelse av naproksen NO304260B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO920315A IT1258143B (it) 1992-09-11 1992-09-11 Compresse a cessione programmata contenenti naproxen

Publications (3)

Publication Number Publication Date
NO933177D0 NO933177D0 (no) 1993-09-07
NO933177L NO933177L (no) 1994-03-14
NO304260B1 true NO304260B1 (no) 1998-11-23

Family

ID=11338458

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933177A NO304260B1 (no) 1992-09-11 1993-09-07 Tablett for programmert avgivelse av naproksen

Country Status (20)

Country Link
US (1) US5480650A (is)
EP (1) EP0587065B1 (is)
KR (1) KR970008157B1 (is)
CN (1) CN1088091A (is)
AT (1) ATE148340T1 (is)
AU (1) AU669552B2 (is)
CA (1) CA2105541C (is)
CZ (1) CZ279853B6 (is)
DE (1) DE69307807T2 (is)
DK (1) DK0587065T3 (is)
ES (1) ES2097952T3 (is)
FI (1) FI933975L (is)
GR (1) GR3022434T3 (is)
IL (1) IL106943A (is)
IS (1) IS1624B (is)
IT (1) IT1258143B (is)
MX (1) MX9305445A (is)
NO (1) NO304260B1 (is)
NZ (1) NZ248574A (is)
ZA (1) ZA936445B (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5609884A (en) * 1992-08-31 1997-03-11 G. D. Searle & Co. Controlled release naproxen sodium plus naproxen combination tablet
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6153225A (en) * 1998-08-13 2000-11-28 Elan Pharma International Limited Injectable formulations of nanoparticulate naproxen
US6165506A (en) * 1998-09-04 2000-12-26 Elan Pharma International Ltd. Solid dose form of nanoparticulate naproxen
CN1434704A (zh) * 1999-12-16 2003-08-06 三叉技术有限责任公司 延长其受体负荷剂量的治疗剂释放的系统和方法
WO2004060355A1 (en) * 2002-12-26 2004-07-22 Pozen Inc. Multilayer Dosage Forms Containing NSAIDs and Triptans
CA2592605C (en) 2004-12-27 2010-12-07 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
AU2009220779A1 (en) * 2008-03-05 2009-09-11 Panacea Biotec Limited Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
US20090252791A1 (en) * 2008-04-02 2009-10-08 Venkata Nookaraju Sreedharala Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug
US20090311335A1 (en) * 2008-06-12 2009-12-17 Scott Jenkins Combination of a triptan and an nsaid
US8618157B2 (en) * 2008-06-20 2013-12-31 Alphapharm Pty. Ltd. Pharmaceutical formulation
PL2919903T3 (pl) 2012-11-14 2020-12-14 W.R. Grace & Co. - Conn. Kompozycje zawierające materiał biologicznie aktywny i nieuporządkowany tlenek nieorganiczny

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.
US5232705A (en) * 1990-08-31 1993-08-03 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5204116A (en) * 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy

Also Published As

Publication number Publication date
CN1088091A (zh) 1994-06-22
NO933177L (no) 1994-03-14
MX9305445A (es) 1994-05-31
NZ248574A (en) 1995-04-27
FI933975A7 (fi) 1994-03-12
IT1258143B (it) 1996-02-20
IL106943A (en) 1998-09-24
US5480650A (en) 1996-01-02
AU669552B2 (en) 1996-06-13
CZ279853B6 (cs) 1995-07-12
IS1624B (is) 1996-10-18
GR3022434T3 (en) 1997-04-30
DE69307807T2 (de) 1997-05-15
NO933177D0 (no) 1993-09-07
ZA936445B (en) 1995-01-31
KR970008157B1 (ko) 1997-05-21
ES2097952T3 (es) 1997-04-16
KR940006577A (ko) 1994-04-25
CA2105541C (en) 1999-01-05
EP0587065A1 (en) 1994-03-16
DK0587065T3 (da) 1997-06-09
ITBO920315A0 (it) 1992-09-11
DE69307807D1 (de) 1997-03-13
CA2105541A1 (en) 1994-03-12
AU4620293A (en) 1994-03-17
ATE148340T1 (de) 1997-02-15
CZ180693A3 (en) 1994-03-16
ITBO920315A1 (it) 1994-03-11
EP0587065B1 (en) 1997-01-29
FI933975A0 (fi) 1993-09-10
IS4069A (is) 1994-03-12
FI933975L (fi) 1994-03-12

Similar Documents

Publication Publication Date Title
RU98111594A (ru) Фармацевтические композиции, включающие флурбипрофен
NO890194L (no) Galenisk middel.
NO20022014D0 (no) Kontrollert frigjöring av hydrocodone formuleringer
FI873225A0 (fi) Menetelmä suun kautta annettavan galeenisen naprokseenikoostumuksen valmistamiseksi, josta aktiiviyhdiste vapautuu ohjelmoidusti
IL78826A0 (en) Sustained release pharmaceutical compositions incorporating degradable delivery system of drugs
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
NO304260B1 (no) Tablett for programmert avgivelse av naproksen
RU93036959A (ru) Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
EP0438147A3 (en) Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
DE69803670D1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
DE68907091D1 (de) Scleroglucan und wirkstoff enthaltende pharmazeutische tabletten und kapselgranulate.
RU96123569A (ru) Лекарственный препарат
IT1270592B (it) Formulazione a rilascio modificato per la somministrazione di farmaci antiinfiammatori non steroidei

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MARCH 2001